Mr Richard Anthony Stefanik, MS RPH | |
11 Mcintosh Ln, Chester, NH 03036-4064 | |
(603) 887-0258 | |
Not Available |
Full Name | Mr Richard Anthony Stefanik |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 11 Mcintosh Ln, Chester, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912112616 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 16957 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Richard Anthony Stefanik, MS RPH 11 Mcintosh Ln, Chester, NH 03036-4064 Ph: (603) 887-0258 | Mr Richard Anthony Stefanik, MS RPH 11 Mcintosh Ln, Chester, NH 03036-4064 Ph: (603) 887-0258 |
News Archive
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
Local ordinances in Appalachian states with weak statewide smoking regulations do not offer most residents adequate protection against second-hand smoke, according to a new study.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
The US Patent Office has recently published the patent application (no. US 2015/0301039), which was filed by the MIPT in May this year and is titled Biological Sensor and a Method of the Production of Biological Sensor. In Russia, this development is already protected by the patent No. 2527699 with a priority date of February 20, 2013. The key feature of the sensor is the use of a linking layer for biomolecule immobilization comprising a thin film of graphene or graphene oxide.
› Verified 9 days ago
Emily Costello, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 162 E Derry Rd, Chester, NH 03036 Phone: 603-716-0533 |